18
16-11-15 1 International Society of Chemotherapy for Infection and Cancer www.ischemo.org

Can we get to zero

Embed Size (px)

Citation preview

Page 1: Can we get to zero

16-11-15

1

International Society of Chemotherapy for Infection and Cancer

www.ischemo.org

Page 2: Can we get to zero

16-11-15

2

PeoplewhosaythatzeroHAIsarepossible…¤ RedefinedHAIs

² CLABSI=2setsofbloodculturesandFpwithgenoFpicallyidenFcalpathogenandbloodculturedrawn(notviathecatheter)negaFve

¤ UsemeanstaFsFcalmethodse.g.“median”¤ PeoplewhohaveneverseenahospitalfromtheinsideandmakewildassumpFons

Page 3: Can we get to zero

16-11-15

3

Page 4: Can we get to zero

16-11-15

4

Swisscheeseaccidentmodel

Swisscheeseaccidentmodel

Handhygiene

AnFbioFcmisuse

Lackingskills

Understaffing

Crosstransmission

Badluck

Page 5: Can we get to zero

16-11-15

5

Handhygiene

AnFbioFcmisuse

Lackingskills

Understaffing

Crosstransmission

Badluck

NI

outbreak

Page 6: Can we get to zero

16-11-15

6

BIG-FAT

Guide

line

EvenbeUerGuideline

VerylongsuperGuideline

LocalRecommendaFon

NaF

onalRecom

men

daFo

n

TinyoverlookedGuideline

RecommendaFon

MoreRecom

mendaFon

Page 7: Can we get to zero

16-11-15

7

Fasces=bundle=strength

¤ AbundleisastructuredwayofimprovingtheprocessesofcareandpaFentoutcome

² asmallsetofevidence-basedpracFces² generallythreetofive² performedcollecFvelyandreliably

¤ ProventoimprovepaFentoutcomes

Page 8: Can we get to zero

16-11-15

8

² Evidencebased

² AchievableinallpaFents

² Covertherelevantaspectsoftheprocedure

Evidencebased

Coverrelevan

taspects

Achievab

leinallpa

?ents

¤ Createacultureofsafety¤ CreateamulF-disciplinaryimprovementteam¤ Ensurefullcommitmentwiththebundleelements² NomorediscussionsabouttheeffecFvenessofthebundleelementsoncestarted

¤ Agreeuponthelengthoftheimprovementperiodandlevelofadherencewithmeasures² IfthatisnotpossibleàDon’tstart!

Page 9: Can we get to zero

16-11-15

9

1 2 3 4 5 6 7 8 Elementcompliance

Element1 Y Y N Y Y Y Y Y 87.5%

Element2 Y N Y N Y Y Y Y 75%

Element3 N Y Y Y Y Y N Y 75%

Element4 Y Y Y Y Y N Y Y 87.5%

Element5 Y Y Y Y Y Y Y N 87.5%

PaFents/procedures

BundleCompliance 12.5%

Surgical Site Infections

Page 10: Can we get to zero

16-11-15

10

Noinfluencepossible

¤  Age

¤  Underlyingdisease

¤  Malignancy

¤  WoundclassificaFon

¤  ProstheFcmaterial

Influence not probable •  Laminarair-flow•  SterilizaFon•  Pre-op hospitalization

Influence by others

•  BMI >30

•  Nicotine use

•  Malnutrition

•  Infection at remote site

Can & should be influenced

•  Surveillance

•  S. aureus colonization

•  Normothermia/hyperoxia

•  Glucose levels

•  Hair-removal

•  Antimicrobial prophylaxis

•  Skin disinfection/decolonization

¤ Hairremoval

¤ AnFmicrobialprophylaxis

¤ Normothermia

¤ DisciplinintheOR?

Page 11: Can we get to zero

16-11-15

11

Page 12: Can we get to zero

16-11-15

12

BundleCompliance

SSIRate

Page 13: Can we get to zero

16-11-15

13

¤ Builtimprovementteam(A-team)

¤ SelectintervenFons¤ Implementinter-venFons

¤ CheckcompliancewithintervenFons

¤ Checkoutcome

Page 14: Can we get to zero

16-11-15

14

PhamD

ClinMicro/ID

ICT

Page 15: Can we get to zero

16-11-15

15

¤ Control/restrictuseofreserve-anFbioFcs¤ SelectandmeasureindicatorsforadequateanFmicrobialuse

¤ Standardizeempirictreatmentandfosteriv-oralswitch

¤ EducaFonandtrainingwithregardtoanFmicrobialuse

¤ DefineallpaFentscategoriesthatneedbed-sideIDconsultaFon

Control/restrictuseofreserve-an?bio?cs.¤ An$bio$cguideline¤ ChecksbyA-team¤ Automa$creportsonDDD’sper1000pat-days¤ Pre-useauthoriza$on¤ Restric$verepor$ng

Page 16: Can we get to zero

16-11-15

16

Selectandmeasureindicatorsforadequatean?microbialuse.¤ Check“useaccordingtoguideline”by

² point-prevalencestudies² dailyconsulta$ons² audits

Standardizeempirictreatmentandfosteriv-oralswitch.¤ On-lineAB-guideline¤ “5xS”aspartofconsulta$on&teaching

² start,safety,streamline,switch,stop

Page 17: Can we get to zero

16-11-15

17

Educa?onandtrainingwithregardtoan?microbialuse¤ Con$nuouseffortofID&ClinMicro

² ownfellows² partofhospitalfelloweduca$on² partofrounds² “switchoftheweek”

Defineallpa?entscategoriesthatneedbed-sideIDconsulta?on¤ Allpa$entswithmeningi$s,endocardi$s,usingan$bio$csforlongerthan2weeks,sufferinganS.aureusbacteremia,andreceivingreservean$bio$csareseenatbed-sidebyID/CM

Page 18: Can we get to zero

16-11-15

18

¤ Real-Fmesurveillance(includingfeedback)oflocalresistancetrendsandresistancerelatedproblemsintheregion/country

¤ AnFbioFc/treatmentguidelines¤ InfecFoncontrolguidelines¤ NaFonalorregionalresistancesurveillance¤ NaFonalorregionalHAIsurveillance¤ AnFmicrobialusesurveillance¤ Auditsbasedonprofessionalstandards(IGZ)¤ CM/ICP/IDspecialistsinallmajorhealthcaresenngsandregionalco-operaFon